{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T17:33:47Z","timestamp":1785346427686,"version":"3.55.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2014,6,13]],"date-time":"2014-06-13T00:00:00Z","timestamp":1402617600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Diagn Ther"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1007\/s40291-014-0108-1","type":"journal-article","created":{"date-parts":[[2014,6,12]],"date-time":"2014-06-12T07:41:52Z","timestamp":1402558912000},"page":"469-482","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Blood-Based Biomarkers in Depression: Emerging Themes in Clinical Research"],"prefix":"10.1007","volume":"18","author":[{"given":"Monica","family":"Uddin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,6,13]]},"reference":[{"key":"108_CR1","unstructured":"Association AP. Diagnostic and statistical manual of mental disorders. 5th ed (DSM-5). Arlington: American Psychiatric Publishing; 2013."},{"key":"108_CR2","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1038\/mp.2008.13","volume":"14","author":"BG Druss","year":"2009","unstructured":"Druss BG, Hwang I, Petukhova M, et al. Impairment in role functioning in mental and chronic medical disorders in the United States: results from the National Comorbidity Survey Replication. Mol Psychiatry. 2009;14:728\u201337.","journal-title":"Mol Psychiatry"},{"key":"108_CR3","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1017\/S1121189X00001421","volume":"18","author":"RC Kessler","year":"2009","unstructured":"Kessler RC, Aguilar-Gaxiola S, Alonso J, et al. The global burden of mental disorders: an update from the WHO World Mental Health (WMH) surveys. Epidemiol Psichiatr Soc. 2009;18:23\u201333.","journal-title":"Epidemiol Psichiatr Soc"},{"key":"108_CR4","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1146\/annurev.publhealth.29.020907.090847","volume":"29","author":"RC Kessler","year":"2008","unstructured":"Kessler RC, Wang PS. The descriptive epidemiology of commonly occurring mental disorders in the United States. Annu Rev Public Health. 2008;29:115\u201329.","journal-title":"Annu Rev Public Health"},{"key":"108_CR5","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0165-0327(93)90026-G","volume":"29","author":"RC Kessler","year":"1993","unstructured":"Kessler RC, McGonagle KA, Swartz M, et al. Sex and depression in the National Comorbidity Survey. I: lifetime prevalence, chronicity and recurrence. J Affect Dis. 1993;29:85\u201396.","journal-title":"J Affect Dis"},{"key":"108_CR6","doi-asserted-by":"crossref","unstructured":"WHO. The global burden of disease: 2004 update. World Health Organization: Geneva; 2004.","DOI":"10.1016\/S0262-1762(04)00136-1"},{"key":"108_CR7","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1136\/bmj.3.5613.285","volume":"3","author":"BJ Carroll","year":"1968","unstructured":"Carroll BJ, Martin FI, Davies B. Resistance to suppression by dexamethasone of plasma 11-O.H.C.S. levels in severe depressive illness. Br Med J. 1968;3:285\u20137.","journal-title":"Br Med J"},{"key":"108_CR8","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.pnpbp.2005.03.014","volume":"29","author":"M Ising","year":"2005","unstructured":"Ising M, Kunzel HE, Binder EB, et al. The combined dexamethasone\/CRH test as a potential surrogate marker in depression. Prog Neuropsychopharmacol Biol Psychiatry. 2005;29:1085\u201393.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"108_CR9","first-page":"538","volume":"2","author":"PE Hayes","year":"1983","unstructured":"Hayes PE, Ettigi P. Dexamethasone suppression test in diagnosis of depressive illness. Clin Pharm. 1983;2:538\u201345.","journal-title":"Clin Pharm"},{"key":"108_CR10","doi-asserted-by":"crossref","first-page":"e9166","DOI":"10.1371\/journal.pone.0009166","volume":"5","author":"E Domenici","year":"2010","unstructured":"Domenici E, Wille DR, Tozzi F, et al. Plasma protein biomarkers for depression and schizophrenia by multi analyte profiling of case\u2013control collections. PLoS One. 2010;5:e9166.","journal-title":"PLoS One"},{"key":"108_CR11","unstructured":"Mehta D, Newport DJ, Frishman G, et al. Early predictive biomarkers for postpartum depression point to a role for estrogen receptor signaling. Psychol Med. 2014;1-14."},{"key":"108_CR12","doi-asserted-by":"crossref","first-page":"e300","DOI":"10.1038\/tp.2013.73","volume":"3","author":"TR Powell","year":"2013","unstructured":"Powell TR, Smith RG, Hackinger S, et al. DNA methylation in interleukin-11 predicts clinical response to antidepressants in GENDEP. Transl Psychiatry. 2013;3:e300.","journal-title":"Transl Psychiatry"},{"key":"108_CR13","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/01.pra.0000413277.11091.25","volume":"18","author":"M Macaluso","year":"2012","unstructured":"Macaluso M, Preskorn SH. How biomarkers will change psychiatry: from clinical trials to practice. Part I: introduction. J Psychiatr Pract. 2012;18:118\u201321.","journal-title":"J Psychiatr Pract"},{"key":"108_CR14","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1038\/npp.2011.331","volume":"37","author":"A Menke","year":"2012","unstructured":"Menke A, Arloth J, Putz B, et al. Dexamethasone stimulated gene expression in peripheral blood is a sensitive marker for glucocorticoid receptor resistance in depressed patients. Neuropsychopharmacology. 2012;37:1455\u201364.","journal-title":"Neuropsychopharmacology"},{"key":"108_CR15","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jpsychires.2009.06.012","volume":"44","author":"TM Buckley","year":"2010","unstructured":"Buckley TM, Schatzberg AF. A pilot study of the phase angle between cortisol and melatonin in major depression\u2014a potential biomarker? J Psychiatr Res. 2010;44:69\u201374.","journal-title":"J Psychiatr Res"},{"key":"108_CR16","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/mp.2011.166","volume":"18","author":"GI Papakostas","year":"2013","unstructured":"Papakostas GI, Shelton RC, Kinrys G, et al. Assessment of a multi-assay, serum-based biological diagnostic test for major depressive disorder: a pilot and replication study. Mol Psychiatry. 2013;18:332\u20139.","journal-title":"Mol Psychiatry"},{"key":"108_CR17","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.biopsych.2010.03.017","volume":"68","author":"S Spijker","year":"2010","unstructured":"Spijker S, Van Zanten JS, De Jong S, et al. Stimulated gene expression profiles as a blood marker of major depressive disorder. Biol Psychiatry. 2010;68:179\u201386.","journal-title":"Biol Psychiatry"},{"key":"108_CR18","doi-asserted-by":"crossref","unstructured":"Guintivano J, Arad M, Gould TD, et al. Antenatal prediction of postpartum depression with blood DNA methylation biomarkers. Mol Psychiatry, 2013.","DOI":"10.1038\/mp.2013.149"},{"key":"108_CR19","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/j.jpsychires.2011.05.002","volume":"45","author":"MS Toups","year":"2011","unstructured":"Toups MS, Greer TL, Kurian BT, et al. Effects of serum brain derived neurotrophic factor on exercise augmentation treatment of depression. J Psychiatr Res. 2011;45:1301\u20136.","journal-title":"J Psychiatr Res"},{"key":"108_CR20","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.pnpbp.2013.09.016","volume":"48","author":"PT Ninan","year":"2014","unstructured":"Ninan PT, Shelton RC, Bao W, et al. BDNF, interleukin-6, and salivary cortisol levels in depressed patients treated with desvenlafaxine. Prog Neuropsychopharmacol Biol Psychiatry. 2014;48:86\u201391.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"108_CR21","doi-asserted-by":"crossref","first-page":"e352","DOI":"10.1038\/tp.2013.129","volume":"4","author":"D Martins-de-Souza","year":"2014","unstructured":"Martins-de-Souza D, Maccarrone G, Ising M, et al. Plasma fibrinogen: now also an antidepressant response marker? Transl Psychiatry. 2014;4:e352.","journal-title":"Transl Psychiatry"},{"key":"108_CR22","doi-asserted-by":"crossref","first-page":"313","DOI":"10.3109\/15622970802573246","volume":"10","author":"JE Piletz","year":"2009","unstructured":"Piletz JE, Halaris A, Iqbal O, et al. Pro-inflammatory biomakers in depression: treatment with venlafaxine. World J Biol Psychiatry. 2009;10:313\u201323.","journal-title":"World J Biol Psychiatry"},{"key":"108_CR23","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3109\/15622975.2013.766762","volume":"15","author":"F Mamdani","year":"2014","unstructured":"Mamdani F, Berlim MT, Beaulieu MM, et al. Pharmacogenomic predictors of citalopram treatment outcome in major depressive disorder. World J Biol Psychiatry. 2014;15:135\u201344.","journal-title":"World J Biol Psychiatry"},{"key":"108_CR24","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1038\/nature03464","volume":"434","author":"K Honda","year":"2005","unstructured":"Honda K, Yanai H, Negishi H, et al. IRF-7 is the master regulator of type-I interferon-dependent immune responses. Nature. 2005;434:772\u20137.","journal-title":"Nature"},{"key":"108_CR25","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.1038\/tp.2011.12","volume":"1","author":"F Mamdani","year":"2011","unstructured":"Mamdani F, Berlim MT, Beaulieu MM, et al. Gene expression biomarkers of response to citalopram treatment in major depressive disorder. Transl Psychiatry. 2011;1:e13.","journal-title":"Transl Psychiatry"},{"key":"108_CR26","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/abbs\/gmp018","volume":"41","author":"X Yan","year":"2009","unstructured":"Yan X, Liu Z, Chen Y. Regulation of TGF-beta signaling by Smad7. Acta Biochim Biophys Sin (Shanghai). 2009;41:263\u201372.","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"108_CR27","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jad.2011.12.041","volume":"137","author":"T Rivera-Baltanas","year":"2012","unstructured":"Rivera-Baltanas T, Olivares JM, Calado-Otero M, et al. Serotonin transporter clustering in blood lymphocytes as a putative biomarker of therapeutic efficacy in major depressive disorder. J Affect Disord. 2012;137:46\u201355.","journal-title":"J Affect Disord"},{"key":"108_CR28","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/mp.2010.133","volume":"17","author":"OM Wolkowitz","year":"2012","unstructured":"Wolkowitz OM, Mellon SH, Epel ES, et al. Resting leukocyte telomerase activity is elevated in major depression and predicts treatment response. Mol Psychiatry. 2012;17:164\u201372.","journal-title":"Mol Psychiatry"},{"key":"108_CR29","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1038\/mp.2011.63","volume":"16","author":"RH Perlis","year":"2011","unstructured":"Perlis RH. Translating biomarkers to clinical practice. Mol Psychiatry. 2011;16:1076\u201387.","journal-title":"Mol Psychiatry"},{"key":"108_CR30","doi-asserted-by":"crossref","first-page":"e88","DOI":"10.1038\/tp.2012.14","volume":"2","author":"T Frodl","year":"2012","unstructured":"Frodl T, Carballedo A, Hughes MM, et al. Reduced expression of glucocorticoid-inducible genes GILZ and SGK-1: high IL-6 levels are associated with reduced hippocampal volumes in major depressive disorder. Transl Psychiatry. 2012;2:e88.","journal-title":"Transl Psychiatry"},{"key":"108_CR31","doi-asserted-by":"crossref","first-page":"e23881","DOI":"10.1371\/journal.pone.0023881","volume":"6","author":"M Fuchikami","year":"2011","unstructured":"Fuchikami M, Morinobu S, Segawa M, et al. DNA methylation profiles of the brain-derived neurotrophic factor (BDNF) gene as a potent diagnostic biomarker in major depression. PLoS ONE. 2011;6:e23881.","journal-title":"PLoS ONE"},{"key":"108_CR32","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1017\/S0033291711002121","volume":"42","author":"ER Katz","year":"2012","unstructured":"Katz ER, Stowe ZN, Newport DJ, et al. Regulation of mRNA expression encoding chaperone and co-chaperone proteins of the glucocorticoid receptor in peripheral blood: association with depressive symptoms during pregnancy. Psychol Med. 2012;42:943\u201356.","journal-title":"Psychol Med"},{"key":"108_CR33","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/01.pra.0000416018.83709.3e","volume":"18","author":"M Macaluso","year":"2012","unstructured":"Macaluso M, Drevets WC, Preskorn SH. How biomarkers will change psychiatry. Part II: Biomarker selection and potential inflammatory markers of depression. J Psychiatr Pract. 2012;18:281\u20136.","journal-title":"J Psychiatr Pract"},{"key":"108_CR34","doi-asserted-by":"crossref","first-page":"e101","DOI":"10.1038\/tp.2012.26","volume":"2","author":"K Pajer","year":"2012","unstructured":"Pajer K, Andrus BM, Gardner W, et al. Discovery of blood transcriptomic markers for depression in animal models and pilot validation in subjects with early-onset major depression. Transl Psychiatry. 2012;2:e101.","journal-title":"Transl Psychiatry"},{"key":"108_CR35","doi-asserted-by":"crossref","first-page":"e31283","DOI":"10.1371\/journal.pone.0031283","volume":"7","author":"Z Yi","year":"2012","unstructured":"Yi Z, Li Z, Yu S, et al. Blood-based gene expression profiles models for classification of subsyndromal symptomatic depression and major depressive disorder. PLoS ONE. 2012;7:e31283.","journal-title":"PLoS ONE"},{"key":"108_CR36","doi-asserted-by":"crossref","unstructured":"Domschke K, Tidow N, Schwarte K, et al. Serotonin transporter gene hypomethylation predicts impaired antidepressant treatment response. Int J Neuropsychopharmacol. 2014;1\u201310.","DOI":"10.1017\/S146114571400039X"},{"key":"108_CR37","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s00228-009-0650-7","volume":"65","author":"E K\u00fc\u00e7\u00fckibrahimo\u011flu","year":"2009","unstructured":"K\u00fc\u00e7\u00fckibrahimo\u011flu E, Saygin MZ, Caliskan M, et al. The change in plasma GABA, glutamine and glutamate levels in fluoxetine- or S-citalopram-treated female patients with major depression. Eur J Clin Pharmacol. 2009;65:571\u20137.","journal-title":"Eur J Clin Pharmacol"},{"key":"108_CR38","doi-asserted-by":"crossref","first-page":"e91076","DOI":"10.1371\/journal.pone.0091076","volume":"9","author":"TR Powell","year":"2014","unstructured":"Powell TR, McGuffin P, D\u2019Souza UM, et al. Putative transcriptomic biomarkers in the inflammatory cytokine pathway differentiate major depressive disorder patients from control subjects and bipolar disorder patients. PLoS ONE. 2014;9:e91076.","journal-title":"PLoS ONE"},{"key":"108_CR39","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1039\/c4mb00068d","volume":"10","author":"L Giusti","year":"2014","unstructured":"Giusti L, Mantua V, Da Valle Y, et al. Search for peripheral biomarkers in patients affected by acutely psychotic bipolar disorder: a proteomic approach. Mol Biosyst. 2014;10:1246\u201354.","journal-title":"Mol Biosyst"},{"key":"108_CR40","doi-asserted-by":"crossref","first-page":"e82","DOI":"10.1038\/tp.2012.3","volume":"2","author":"E Schwarz","year":"2012","unstructured":"Schwarz E, Guest PC, Steiner J, et al. Identification of blood-based molecular signatures for prediction of response and relapse in schizophrenia patients. Transl Psychiatry. 2012;2:e82.","journal-title":"Transl Psychiatry"},{"key":"108_CR41","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1017\/S1368980011002904","volume":"15","author":"LM Bodnar","year":"2012","unstructured":"Bodnar LM, Wisner KL, Luther JF, et al. An exploratory factor analysis of nutritional biomarkers associated with major depression in pregnancy. Public Health Nutr. 2012;15:1078\u201386.","journal-title":"Public Health Nutr"},{"key":"108_CR42","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.biopsych.2008.05.035","volume":"64","author":"G Cizza","year":"2008","unstructured":"Cizza G, Marques AH, Eskandari F, et al. Elevated neuroimmune biomarkers in sweat patches and plasma of premenopausal women with major depressive disorder in remission: the POWER study. Biol Psychiatry. 2008;64:907\u201311.","journal-title":"Biol Psychiatry"},{"key":"108_CR43","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.jad.2012.05.065","volume":"145","author":"G Einvik","year":"2013","unstructured":"Einvik G, Flyvbjerg A, Hrubos-Strom H, et al. Novel cardiovascular risk markers in depression: no association between depressive symptoms and osteoprotegerin or adiponectin in persons at high risk for sleep apnea. J Affect Disord. 2013;145:400\u20134.","journal-title":"J Affect Disord"},{"key":"108_CR44","doi-asserted-by":"crossref","first-page":"e96869","DOI":"10.1371\/journal.pone.0096869","volume":"9","author":"Y He","year":"2014","unstructured":"He Y, Tang J, Li Z, et al. Leukocyte mitochondrial DNA copy number in blood is not associated with major depressive disorder in young adults. PLoS ONE. 2014;9:e96869.","journal-title":"PLoS ONE"},{"key":"108_CR45","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jad.2014.02.022","volume":"159","author":"I Lopez-Vilchez","year":"2014","unstructured":"Lopez-Vilchez I, Serra-Millas M, Navarro V, et al. Prothrombotic platelet phenotype in major depression: downregulation by antidepressant treatment. J Affect Disord. 2014;159:39\u201345.","journal-title":"J Affect Disord"},{"key":"108_CR46","doi-asserted-by":"crossref","first-page":"e49677","DOI":"10.1371\/journal.pone.0049677","volume":"7","author":"JR Teyssier","year":"2012","unstructured":"Teyssier JR, Chauvet-Gelinier JC, Ragot S, et al. Up-regulation of leucocytes genes implicated in telomere dysfunction and cellular senescence correlates with depression and anxiety severity scores. PLoS ONE. 2012;7:e49677.","journal-title":"PLoS ONE"},{"key":"108_CR47","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.biopsych.2008.04.023","volume":"64","author":"V Vaccarino","year":"2008","unstructured":"Vaccarino V, Brennan ML, Miller AH, et al. Association of major depressive disorder with serum myeloperoxidase and other markers of inflammation: a twin study. Biol Psychiatry. 2008;64:476\u201383.","journal-title":"Biol Psychiatry"}],"container-title":["Molecular Diagnosis & Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40291-014-0108-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40291-014-0108-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40291-014-0108-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,7]],"date-time":"2022-04-07T21:35:25Z","timestamp":1649367325000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40291-014-0108-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6,13]]},"references-count":47,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["108"],"URL":"https:\/\/doi.org\/10.1007\/s40291-014-0108-1","relation":{},"ISSN":["1177-1062","1179-2000"],"issn-type":[{"value":"1177-1062","type":"print"},{"value":"1179-2000","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6,13]]}}}